Krill-derived chitin products and methods of making same
Methods of producing a chitin composition by which the properties of the chitin composition derived from krill, such as molecular weight (chain length) and degree of acetylation are reproducible, are claimed. Such reproducible production methods allow for a wide use of the chitin composition end products in pharmaceutical and biomedical applications. The methods also allow for the production of chitin compositions which preserve the native state of chitin.
1. A composition comprising:
a deproteinized crustacean chitin, said deproteinized crustacean chitin having:
a crystallinity index of between 80% to 90%;
an average molecular weight of less than 700 kDa; and
a purity of greater than 90% of said composition.
2. The composition of claim 1 , wherein said chitin is a krill chitin.
3. The composition of claim 1 , wherein said crystallinity index (CI) is selected from the group consisting of between 80% to 87%, and 80% to 86%.
4. The composition of claim 1 , wherein said purity is selected from the group consisting of at least 95%, and at least 99%.
5. The composition of claim 1 , comprising a protein concentration selected from the group consisting of less than 5%, less than 1%, and less than 0.1%.
6. The composition of claim 1 , comprising a lipid concentration selected from the group consisting of less than 10%, less than 5%, less than 1% and less than 0.1%.
7. The composition of claim 1 , wherein said average molecular weight is selected from the group consisting of between 300 kDa-800 kDa and between 400 kDa-700 kDa.
8. The composition of claim 1 , comprising a trace mineral concentration selected from the group consisting of less than 0.5 ppm, less than 1 ppm and less than 0.1 ppm.
9. The composition of claim 8 , wherein said trace mine al is selected from the group consisting of iron, calcium, phosphorus, magnesium, potassium, zinc, nickel, selenium, fluoride and copper.
10. The composition of claim 1 , wherein said composition is a pharmaceutical composition.
11. The composition of claim 10 , wherein said pharmaceutical composition is formulated into a pharmaceutical preparation.
12. The composition of claim 11 , wherein said pharmaceutical preparation is selected from the group consisting of a tablet and a capsule.
13. The composition of claim 1 , wherein said composition is a food additive.
14. A biomedical device comprising a composition comprising a deproteinized crustacean chitin, said chitin having a crystallinity index between 80% to 90%; an average molecular weight of less than 700 kDa; and a purity of greater than 90% of said composition.
15. The biomedical device of claim 14 , wherein said device is selected from the group consisting of a wound dressing, a biofilm, an artificial skin, a packaging, and a vaccine adjuvant.
16. The biomedical device of claim 14 , wherein said composition comprises a trace mineral concentration of less than 5 ppm.
17. The biomedical device of claim 14 , wherein said composition comprises a protein concentration of less than 5%.